Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioNTech SE

104.37
+0.37000.36%
Volume:785.22K
Turnover:82.51M
Market Cap:25.05B
PE:-36.39
High:107.47
Open:103.72
Low:103.45
Close:104.00
Loading ...

Novavax (NasdaqGS:NVAX) Study Shows Reduced Symptoms With New COVID-19 Vaccine Formula

Simply Wall St.
·
17 Apr

Abbott Labs Clocks Q1 Profit Beat, CEO Says Diversification And Execution Enable Navigation During Uncertainty

Benzinga
·
16 Apr

GeoVax Provides Update on BARDA Project NextGen and Outlines 2025 Business Momentum

NewMediaWire
·
16 Apr

Abbott Reports First-Quarter 2025 Results and Reaffirms Full-Year Guidance

PR Newswire
·
16 Apr

Why Typhoid Trump and COVID are so similar

The Sydney Morning Herald
·
16 Apr

GeoVax received written notification from ATI to stop Phase 2 COVID-19 work

TIPRANKS
·
16 Apr

GeoVax's COVID-19 Vaccine Study Ended by Funding Agency; Shares Fall

MT Newswires Live
·
16 Apr

Standard Chartered Bank Expects Stablecoin Total Supply to Skyrocket to $20 Trillion by 2028

Blockbeats
·
15 Apr

Strength Seen in BioNTech (BNTX): Can Its 6.0% Jump Turn into More Strength?

Zacks
·
15 Apr

GeoVax to Present Clinical Data at Upcoming April Industry Events

NewMediaWire
·
15 Apr

Novavax Says COVID-19 Vaccine Induces Fewer Symptoms Compared With Pfizer's Vaccine

MT Newswires Live
·
15 Apr

SHIELD-Utah Study Shows Novavax's COVID-19 Vaccine Induces Lower Reactogenicity Symptoms Compared to mRNA

PR Newswire
·
15 Apr

Johnson & Johnson Reports Q1 2025 Results

Business Wire
·
15 Apr

GeoVax Labs Faces Contract Termination for COVID-19 Vaccine

TIPRANKS
·
15 Apr

BioNTech SE ADR Rises 6.0%, Outperforms Market

Dow Jones
·
15 Apr

BioNTech (NasdaqGS:BNTX) Sees 11% Stock Increase Over Last Week

Simply Wall St.
·
15 Apr

European Equities Traded in the US as American Depositary Receipts Rise in Monday Trading

MT Newswires Live
·
14 Apr

Stock Track | BioNTech SE Surges 5% Pre-Market on Morgan Stanley's Buy Rating and $140 Price Target

Stock Track
·
14 Apr

Stock Track | BioNTech SE Soars 5% After Morgan Stanley Reaffirms Buy Rating with $140 Price Target

Stock Track
·
14 Apr

Zai Lab Limited (ZLAB) Moves 21.5% Higher: Will This Strength Last?

Zacks
·
14 Apr